MetLife (NYSE:MET) PT Raised to $83.00

MetLife (NYSE:METGet Rating) had its price target boosted by equities research analysts at Wells Fargo & Company from $81.00 to $83.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The brokerage currently has an “overweight” rating on the financial services provider’s stock. Wells Fargo & Company‘s price objective would indicate a potential upside of 19.54% from the stock’s current price.

Other research analysts have also issued reports about the company. Jefferies Financial Group lowered MetLife from a “buy” rating to a “hold” rating and lowered their price objective for the stock from $86.00 to $82.00 in a research report on Friday, December 9th. StockNews.com initiated coverage on MetLife in a research report on Wednesday, October 12th. They issued a “hold” rating for the company. Raymond James assumed coverage on MetLife in a research report on Wednesday, September 21st. They issued a “market perform” rating for the company. The Goldman Sachs Group downgraded MetLife from a “buy” rating to a “neutral” rating and reduced their target price for the company from $80.00 to $78.00 in a research note on Monday, January 9th. Finally, Morgan Stanley raised their target price on MetLife from $87.00 to $88.00 and gave the company an “overweight” rating in a research note on Tuesday, January 10th. Four analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $80.18.

MetLife Stock Down 1.0 %

Shares of NYSE:MET opened at $69.43 on Wednesday. The firm has a market cap of $54.48 billion, a P/E ratio of 26.10, a P/E/G ratio of 4.86 and a beta of 1.07. The company has a quick ratio of 0.14, a current ratio of 0.14 and a debt-to-equity ratio of 0.60. MetLife has a 12-month low of $57.41 and a 12-month high of $77.36. The business has a fifty day simple moving average of $73.44 and a 200 day simple moving average of $68.19.

MetLife (NYSE:METGet Rating) last posted its quarterly earnings data on Wednesday, November 2nd. The financial services provider reported $1.21 earnings per share for the quarter, topping the consensus estimate of $1.18 by $0.03. MetLife had a return on equity of 13.60% and a net margin of 3.26%. The firm had revenue of $23.69 billion during the quarter, compared to analyst estimates of $19.89 billion. Analysts predict that MetLife will post 7.08 earnings per share for the current year.

Insider Buying and Selling at MetLife

In other news, EVP Susan M. Podlogar sold 3,000 shares of the business’s stock in a transaction that occurred on Tuesday, December 20th. The stock was sold at an average price of $71.91, for a total value of $215,730.00. Following the transaction, the executive vice president now owns 46,193 shares in the company, valued at approximately $3,321,738.63. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other news, EVP Steven J. Goulart sold 29,401 shares of the business’s stock in a transaction that occurred on Monday, December 12th. The stock was sold at an average price of $71.88, for a total value of $2,113,343.88. Following the transaction, the executive vice president now owns 273,310 shares in the company, valued at approximately $19,645,522.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Susan M. Podlogar sold 3,000 shares of the business’s stock in a transaction that occurred on Tuesday, December 20th. The stock was sold at an average price of $71.91, for a total value of $215,730.00. Following the completion of the transaction, the executive vice president now owns 46,193 shares in the company, valued at approximately $3,321,738.63. The disclosure for this sale can be found here. In the last quarter, insiders sold 37,401 shares of company stock worth $2,706,824. Insiders own 0.26% of the company’s stock.

Hedge Funds Weigh In On MetLife

Hedge funds and other institutional investors have recently modified their holdings of the business. Stratos Wealth Advisors LLC raised its holdings in shares of MetLife by 133.7% in the 4th quarter. Stratos Wealth Advisors LLC now owns 11,077 shares of the financial services provider’s stock worth $802,000 after purchasing an additional 6,338 shares during the period. Arlington Partners LLC bought a new stake in shares of MetLife in the 4th quarter worth approximately $35,000. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH raised its holdings in shares of MetLife by 11.3% in the 4th quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH now owns 600,719 shares of the financial services provider’s stock worth $43,474,000 after purchasing an additional 61,120 shares during the period. Catalyst Financial Partners LLC bought a new stake in shares of MetLife in the 4th quarter worth approximately $298,000. Finally, Pendal Group Ltd bought a new stake in shares of MetLife in the 4th quarter worth approximately $577,000. Hedge funds and other institutional investors own 88.15% of the company’s stock.

About MetLife

(Get Rating)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

See Also

Analyst Recommendations for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.